Related Experiment Videos
Short- and long-term risk of cardiovascular events in white-coat hypertension
S D Pierdomenico1, D Lapenna, R Di Mascio
1Department of Medicine and Aging Science, University Gabriele d'Annunzio, Chieti, Italy. pierdomenico@unich.it
Insights
White-coat hypertension poses a lower cardiovascular risk than sustained hypertension, similar to normotension. This study found no significant difference in cardiovascular events between white-coat hypertension and normal blood pressure over the long term.
Area of Science:
- Cardiology
- Hypertension Research
- Clinical Outcomes
Background:
- The prognostic significance of white-coat hypertension (WCH) remains uncertain.
- Distinguishing WCH from sustained hypertension (SH) is crucial for accurate cardiovascular risk assessment.
Purpose of the Study:
- To compare cardiovascular outcomes in patients with sustained hypertension, white-coat hypertension, and normotension.
- To evaluate the short-term and long-term prognostic impact of WCH.
Main Methods:
- A cohort study involving 1732 patients with clinical hypertension (1333 SH, 399 WCH) and 305 normotensive individuals.
- WCH defined as clinical hypertension with daytime blood pressure <135/85 mm Hg.
- Follow-up for a mean of 6.4 years to track fatal and nonfatal cardiovascular events.
Main Results:
- The event rate per 100 patient-years was 0.38 for normotension, 0.44 for WCH, and 1.58 for SH.
- Cox regression analysis revealed significantly higher cardiovascular risk in SH compared to WCH (RR 3.32).
- No significant difference in cardiovascular risk was observed between WCH and normotension.
Conclusions:
- Cardiovascular risk in white-coat hypertension is significantly lower than in sustained hypertension.
- White-coat hypertension does not confer a significantly different cardiovascular risk compared to normotension.
- These findings support that WCH may not require the same level of intervention as sustained hypertension.
Abstract:
The prognostic impact of white-coat hypertension is not yet completely clear. In this study, we investigated cardiovascular outcome in sustained hypertension, white-coat hypertension and normotension in the short and long term. The occurrence of fatal and nonfatal cardiovascular events was evaluated in 1732 subjects with clinical hypertension (1333 with sustained and 399 with white-coat hypertension) and 305 with normotension. White-coat hypertension was defined as clinical hypertension and daytime blood pressure <135/85 mm Hg. During the period of observation (mean 6.4 years, range 0.7-13.1), 152 cardiovascular events occurred. The event rate per 100 patient-years in subjects with normotension, white-coat and sustained hypertension was 0.38, 0.44 and 1.58, respectively. Event-free survival was significantly different among the groups (P<0.0001). After adjustment for several covariates, Cox regression analysis showed that cardiovascular risk was significantly higher in patients with sustained than in those with white-coat hypertension (relative risk (RR) 3.32, 95% confidence interval (CI) 1.81-6.12, P=0.0001), whereas there was no significant difference between normotension and white-coat hypertension. When events were analysed separately, cardiac and cerebrovascular risk were significantly higher in sustained than in white-coat hypertension (RR 4.16, 95% CI 1.48-11.6, P=0.007, and RR 4.12, 95% CI 1.62-10.5, P=0.003, respectively) and not significantly different between white-coat hypertension and normotension. Event-free survival had the same trend for the whole period of observation both when cardiovascular events were examined together and when cardiac and cerebrovascular events were analysed separately. In this study, cardiovascular risk in white-coat hypertension was significantly lower than that in sustained hypertension and not significantly different from normotension both in the short and long term.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension II: Pathophysiology
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension and Regulation of Blood Pressure